Task: Answer the multiple-choice question.
Query: Which compound exhibits a -18.350% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a Cn1cnc2cc(NCc3ccc(Cl)cc3)ccc21
b CSc1nc(=S)n(Cc2ccccc2)c(C)c1C(C)=O
c Cc1ccnc(NC(=O)C2CCCN(S(=O)(=O)c3cnc[nH]3)C2)c1
d CCOc1ccccc1NC(=O)Cc1cccs1
e CCC1(CC)Cc2ccccc2C(N)=C1C#N
Answer: a. Cn1cnc2cc(NCc3ccc(Cl)cc3)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1cnc2cc(NCc3ccc(Cl)cc3)ccc21
Cn1cnc2cc(NCc3ccc(Cl)cc3)ccc21
N-[(4-chlorophenyl)methyl]-1-methylbenzimidazol-5-amine